Cargando…

The Spectrum of Paraneoplastic Cutaneous Vasculitis in a Defined Population: Incidence and Clinical Features

Cutaneous vasculitis may be associated with malignancies, and may behave as a paraneoplastic syndrome. This association has been reported in a variable proportion of patients depending on population selection. We conducted the current study to assess the frequency, clinical features, treatment, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Loricera, Javier, Calvo-Río, Vanesa, Ortiz-Sanjuán, Francisco, González-López, Marcos A., Fernández-Llaca, Hector, Rueda-Gotor, Javier, Gonzalez-Vela, Maria C., Alvarez, Lino, Mata, Cristina, González-Lamuño, Domingo, Martínez-Taboada, Victor M., González-Gay, Miguel A., Blanco, Ricardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4553993/
https://www.ncbi.nlm.nih.gov/pubmed/24145696
http://dx.doi.org/10.1097/MD.0000000000000009
_version_ 1782387988591804416
author Loricera, Javier
Calvo-Río, Vanesa
Ortiz-Sanjuán, Francisco
González-López, Marcos A.
Fernández-Llaca, Hector
Rueda-Gotor, Javier
Gonzalez-Vela, Maria C.
Alvarez, Lino
Mata, Cristina
González-Lamuño, Domingo
Martínez-Taboada, Victor M.
González-Gay, Miguel A.
Blanco, Ricardo
author_facet Loricera, Javier
Calvo-Río, Vanesa
Ortiz-Sanjuán, Francisco
González-López, Marcos A.
Fernández-Llaca, Hector
Rueda-Gotor, Javier
Gonzalez-Vela, Maria C.
Alvarez, Lino
Mata, Cristina
González-Lamuño, Domingo
Martínez-Taboada, Victor M.
González-Gay, Miguel A.
Blanco, Ricardo
author_sort Loricera, Javier
collection PubMed
description Cutaneous vasculitis may be associated with malignancies, and may behave as a paraneoplastic syndrome. This association has been reported in a variable proportion of patients depending on population selection. We conducted the current study to assess the frequency, clinical features, treatment, and outcome of paraneoplastic vasculitis in a large unselected series of 766 patients with cutaneous vasculitis diagnosed at a single university hospital. Sixteen patients (10 men and 6 women; mean age ± standard deviation, 67.94 ± 14.20 yr; range, 40–85 yr) presenting with cutaneous vasculitis were ultimately diagnosed as having an underlying malignancy. They constituted 3.80% of the 421 adult patients. There were 9 hematologic and 7 solid underlying malignancies. Skin lesions were the initial clinical presentation in all of them, and the median interval from the onset of cutaneous vasculitis to the diagnosis of the malignancy was 17 days (range, 8–50 d). The most frequent skin lesions were palpable purpura (15 patients). Other clinical manifestations included constitutional syndrome (10 patients) and arthralgia and/or arthritis (4 cases). Hematologic cytopenias (11 cases) as well as immature peripheral blood cells (6 cases) were frequently observed in the full blood cell count, especially in those with vasculitis associated with hematologic malignancies. Specific treatment for vasculitis was prescribed in 10 patients; nonsteroidal antiinflammatory drugs (4 patients), corticosteroids (3 patients), chloroquine (1 patient), antihistamines (1 patient), and cyclophosphamide (1 patient). Ten patients died due to the malignancy and 6 patients recovered following malignancy therapy. Patients with paraneoplastic vasculitis were older, more frequently had constitutional syndrome, and less frequently had organ damage due to the vasculitis than the remaining patients with cutaneous vasculitis. In summary, cutaneous paraneoplastic vasculitis is an entity not uncommonly encountered by clinicians. The most common underlying malignancy is generally hematologic. In these cases the presence of cytopenias and immature cells may be red flags for the diagnosis of cancer. In patients with paraneoplastic cutaneous vasculitis, the prognosis depends on the underlying neoplasia.
format Online
Article
Text
id pubmed-4553993
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-45539932015-10-27 The Spectrum of Paraneoplastic Cutaneous Vasculitis in a Defined Population: Incidence and Clinical Features Loricera, Javier Calvo-Río, Vanesa Ortiz-Sanjuán, Francisco González-López, Marcos A. Fernández-Llaca, Hector Rueda-Gotor, Javier Gonzalez-Vela, Maria C. Alvarez, Lino Mata, Cristina González-Lamuño, Domingo Martínez-Taboada, Victor M. González-Gay, Miguel A. Blanco, Ricardo Medicine (Baltimore) Original Study Cutaneous vasculitis may be associated with malignancies, and may behave as a paraneoplastic syndrome. This association has been reported in a variable proportion of patients depending on population selection. We conducted the current study to assess the frequency, clinical features, treatment, and outcome of paraneoplastic vasculitis in a large unselected series of 766 patients with cutaneous vasculitis diagnosed at a single university hospital. Sixteen patients (10 men and 6 women; mean age ± standard deviation, 67.94 ± 14.20 yr; range, 40–85 yr) presenting with cutaneous vasculitis were ultimately diagnosed as having an underlying malignancy. They constituted 3.80% of the 421 adult patients. There were 9 hematologic and 7 solid underlying malignancies. Skin lesions were the initial clinical presentation in all of them, and the median interval from the onset of cutaneous vasculitis to the diagnosis of the malignancy was 17 days (range, 8–50 d). The most frequent skin lesions were palpable purpura (15 patients). Other clinical manifestations included constitutional syndrome (10 patients) and arthralgia and/or arthritis (4 cases). Hematologic cytopenias (11 cases) as well as immature peripheral blood cells (6 cases) were frequently observed in the full blood cell count, especially in those with vasculitis associated with hematologic malignancies. Specific treatment for vasculitis was prescribed in 10 patients; nonsteroidal antiinflammatory drugs (4 patients), corticosteroids (3 patients), chloroquine (1 patient), antihistamines (1 patient), and cyclophosphamide (1 patient). Ten patients died due to the malignancy and 6 patients recovered following malignancy therapy. Patients with paraneoplastic vasculitis were older, more frequently had constitutional syndrome, and less frequently had organ damage due to the vasculitis than the remaining patients with cutaneous vasculitis. In summary, cutaneous paraneoplastic vasculitis is an entity not uncommonly encountered by clinicians. The most common underlying malignancy is generally hematologic. In these cases the presence of cytopenias and immature cells may be red flags for the diagnosis of cancer. In patients with paraneoplastic cutaneous vasculitis, the prognosis depends on the underlying neoplasia. Wolters Kluwer Health 2013-11 2013-11-14 /pmc/articles/PMC4553993/ /pubmed/24145696 http://dx.doi.org/10.1097/MD.0000000000000009 Text en Copyright © 2013 by Lippincott Williams & Wilkins
spellingShingle Original Study
Loricera, Javier
Calvo-Río, Vanesa
Ortiz-Sanjuán, Francisco
González-López, Marcos A.
Fernández-Llaca, Hector
Rueda-Gotor, Javier
Gonzalez-Vela, Maria C.
Alvarez, Lino
Mata, Cristina
González-Lamuño, Domingo
Martínez-Taboada, Victor M.
González-Gay, Miguel A.
Blanco, Ricardo
The Spectrum of Paraneoplastic Cutaneous Vasculitis in a Defined Population: Incidence and Clinical Features
title The Spectrum of Paraneoplastic Cutaneous Vasculitis in a Defined Population: Incidence and Clinical Features
title_full The Spectrum of Paraneoplastic Cutaneous Vasculitis in a Defined Population: Incidence and Clinical Features
title_fullStr The Spectrum of Paraneoplastic Cutaneous Vasculitis in a Defined Population: Incidence and Clinical Features
title_full_unstemmed The Spectrum of Paraneoplastic Cutaneous Vasculitis in a Defined Population: Incidence and Clinical Features
title_short The Spectrum of Paraneoplastic Cutaneous Vasculitis in a Defined Population: Incidence and Clinical Features
title_sort spectrum of paraneoplastic cutaneous vasculitis in a defined population: incidence and clinical features
topic Original Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4553993/
https://www.ncbi.nlm.nih.gov/pubmed/24145696
http://dx.doi.org/10.1097/MD.0000000000000009
work_keys_str_mv AT loricerajavier thespectrumofparaneoplasticcutaneousvasculitisinadefinedpopulationincidenceandclinicalfeatures
AT calvoriovanesa thespectrumofparaneoplasticcutaneousvasculitisinadefinedpopulationincidenceandclinicalfeatures
AT ortizsanjuanfrancisco thespectrumofparaneoplasticcutaneousvasculitisinadefinedpopulationincidenceandclinicalfeatures
AT gonzalezlopezmarcosa thespectrumofparaneoplasticcutaneousvasculitisinadefinedpopulationincidenceandclinicalfeatures
AT fernandezllacahector thespectrumofparaneoplasticcutaneousvasculitisinadefinedpopulationincidenceandclinicalfeatures
AT ruedagotorjavier thespectrumofparaneoplasticcutaneousvasculitisinadefinedpopulationincidenceandclinicalfeatures
AT gonzalezvelamariac thespectrumofparaneoplasticcutaneousvasculitisinadefinedpopulationincidenceandclinicalfeatures
AT alvarezlino thespectrumofparaneoplasticcutaneousvasculitisinadefinedpopulationincidenceandclinicalfeatures
AT matacristina thespectrumofparaneoplasticcutaneousvasculitisinadefinedpopulationincidenceandclinicalfeatures
AT gonzalezlamunodomingo thespectrumofparaneoplasticcutaneousvasculitisinadefinedpopulationincidenceandclinicalfeatures
AT martineztaboadavictorm thespectrumofparaneoplasticcutaneousvasculitisinadefinedpopulationincidenceandclinicalfeatures
AT gonzalezgaymiguela thespectrumofparaneoplasticcutaneousvasculitisinadefinedpopulationincidenceandclinicalfeatures
AT blancoricardo thespectrumofparaneoplasticcutaneousvasculitisinadefinedpopulationincidenceandclinicalfeatures
AT loricerajavier spectrumofparaneoplasticcutaneousvasculitisinadefinedpopulationincidenceandclinicalfeatures
AT calvoriovanesa spectrumofparaneoplasticcutaneousvasculitisinadefinedpopulationincidenceandclinicalfeatures
AT ortizsanjuanfrancisco spectrumofparaneoplasticcutaneousvasculitisinadefinedpopulationincidenceandclinicalfeatures
AT gonzalezlopezmarcosa spectrumofparaneoplasticcutaneousvasculitisinadefinedpopulationincidenceandclinicalfeatures
AT fernandezllacahector spectrumofparaneoplasticcutaneousvasculitisinadefinedpopulationincidenceandclinicalfeatures
AT ruedagotorjavier spectrumofparaneoplasticcutaneousvasculitisinadefinedpopulationincidenceandclinicalfeatures
AT gonzalezvelamariac spectrumofparaneoplasticcutaneousvasculitisinadefinedpopulationincidenceandclinicalfeatures
AT alvarezlino spectrumofparaneoplasticcutaneousvasculitisinadefinedpopulationincidenceandclinicalfeatures
AT matacristina spectrumofparaneoplasticcutaneousvasculitisinadefinedpopulationincidenceandclinicalfeatures
AT gonzalezlamunodomingo spectrumofparaneoplasticcutaneousvasculitisinadefinedpopulationincidenceandclinicalfeatures
AT martineztaboadavictorm spectrumofparaneoplasticcutaneousvasculitisinadefinedpopulationincidenceandclinicalfeatures
AT gonzalezgaymiguela spectrumofparaneoplasticcutaneousvasculitisinadefinedpopulationincidenceandclinicalfeatures
AT blancoricardo spectrumofparaneoplasticcutaneousvasculitisinadefinedpopulationincidenceandclinicalfeatures